Aspiriant LLC’s iShares Global REIT ETF REET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$294K Sell
11,681
-3,060
-21% -$79.5K 0.01% 279
2025
Q4
$368K Sell
14,741
-852
-5% -$21.5K 0.01% 250
2025
Q3
$399K Sell
15,593
-4,611
-23% -$116K 0.01% 221
2025
Q2
$499K Sell
20,204
-8,092
-29% -$196K 0.02% 199
2025
Q1
$686K Sell
28,296
-10,208
-27% -$249K 0.02% 163
2024
Q4
$923K Sell
38,504
-12,889
-25% -$329K 0.03% 147
2024
Q3
$1.37M Sell
51,393
-5,614
-10% -$142K 0.05% 120
2024
Q2
$1.33M Sell
57,007
-4,239
-7% -$96.9K 0.05% 120
2024
Q1
$1.45M Sell
61,246
-13,913
-19% -$326K 0.06% 115
2023
Q4
$1.82M Sell
75,159
-7,320
-9% -$160K 0.08% 97
2023
Q3
$1.75M Sell
82,479
-16,216
-16% -$371K 0.09% 96
2023
Q2
$2.27M Sell
98,695
-3,797
-4% -$86.5K 0.11% 86
2023
Q1
$2.35M Sell
102,492
-1,119
-1% -$26.4K 0.12% 81
2022
Q4
$2.35M Buy
+103,611
New +$2.31M 0.12% 79

Other funds holding REET

Aspiriant LLC's REET Position: Q1 2026 in Review

Aspiriant LLC reduced its iShares Global REIT ETF (REET) stake by 21% in Q1 2026, selling an estimated $79.5K and leaving 11,681 shares worth $294K. The position accounts for 0.01% of the portfolio, ranked #279.

Aspiriant LLC first reported a position in REET in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.35M in Q4 2022. 299 funds tracked by Wall St. Rank hold REET as of Q1 2026.

  • Aspiriant LLC held 11,681 shares of iShares Global REIT ETF worth $294K as of Q1 2026.
  • Aspiriant LLC sold 3,060 iShares Global REIT ETF shares in Q1 2026, an estimated $79.5K.
  • iShares Global REIT ETF made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #279 holding.
  • Aspiriant LLC first reported a position in iShares Global REIT ETF in Q4 2022 and has held it in 14 quarters since.
  • Aspiriant LLC's iShares Global REIT ETF position peaked at $2.35M in Q4 2022.
  • 299 funds tracked by Wall St. Rank held iShares Global REIT ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.